gptkbp:instance_of
|
gptkb:healthcare_organization
|
gptkbp:bfsLayer
|
4
|
gptkbp:bfsParent
|
gptkb:Rituxan
|
gptkbp:affects
|
gptkb:skincare_product
kidneys
lungs
joints
blood vessels
eyes
upper respiratory tract
|
gptkbp:associated_with
|
ANCA antibodies
|
gptkbp:caused_by
|
gptkb:musician
inflammation
|
gptkbp:complications
|
hearing loss
lung damage
skin lesions
nerve damage
kidney failure
|
gptkbp:contains_allergens
|
gptkb:theorem
|
gptkbp:current_use
|
gptkb:microscopic_polyangiitis
gptkb:Churg-Strauss_syndrome
gptkb:Wegener's_granulomatosis
|
gptkbp:first_described_by
|
1950s
|
gptkbp:gender
|
more common in males
|
https://www.w3.org/2000/01/rdf-schema#label
|
granulomatosis with polyangiitis
|
gptkbp:is_monitored_by
|
regular follow-ups
lung function tests
kidney function tests
ANCA levels
|
gptkbp:is_popular_in
|
rare
|
gptkbp:named_after
|
gptkb:Friedrich_Wegener
|
gptkbp:premiered_on
|
adulthood
|
gptkbp:research
|
ongoing
|
gptkbp:risk_factor
|
smoking
genetic predisposition
infections
environmental exposures
|
gptkbp:scientific_classification
|
small vessel vasculitis
|
gptkbp:social_responsibility
|
CT scan
variable
blood tests
biopsy
depends on severity
depends on treatment
|
gptkbp:symptoms
|
fatigue
cough
sinusitis
hematuria
|
gptkbp:treatment
|
gptkb:methotrexate
gptkb:theorem
gptkb:cyclophosphamide
gptkb:rituximab
gptkb:azathioprine
corticosteroids
plasma exchange
immunosuppressants
|